CDH1 and breast carcinoma: For example, it was found that 62% of cases of breast cancer had increased E-cadherin at the metastatic site compared to the primary tumor, showing the possibility that tumor cells never lost E-cadherin expression or that E-cadherin expression is perturbed minimally [11].